Seattle’s Integrated Diagnostics acquired by lung cancer technology company Biodesix Colorado-based Biodesix, a company that creates technology around lung cancer, announced that it has acquired Seattle’s Integrated Diagnostics for an… Read More
Liquid biopsy startup RareCyte announces $30M round and new CEO to fuel rare cell detection A liquid biopsy sounds like far-future tech: It’s essentially a blood test that can detect cancer by analyzing DNA from… Read More
Stealthy University of Washington spinout raises cash for non-invasive cancer-diagnosing liquid biopsy University of Washington spinout Bellwether Bio isn’t disclosing much about its technology, but what it is sharing could be promising… Read More
